Plus Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Plus Therapeutics, Inc. (PSTV) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.088.5518.1218.408.35
Short-Term Investments3.530.000.000.000.00
Cash & Short-Term Investments3.618.5518.1218.408.35
Accounts Receivable0.570.000.000.010.00
Inventory0.000.000.000.000.00
Other Current Assets0.651.053.701.320.77
Total Current Assets5.269.8321.8219.729.18
Non-Current Assets
Property, Plant & Equipment (Net)0.521.111.571.822.46
Goodwill0.370.370.370.370.37
Intangible Assets0.470.040.090.050.09
Other Non-Current Assets0.010.030.010.020.02
Total Non-Current Assets1.371.552.052.260.00
Total Assets6.6311.3923.8721.9812.11
Current Liabilities
Accounts Payable9.474.768.362.610.79
Short-Term Debt3.343.981.611.616.34
Current Portion of Long-Term Debt0.003.981.611.616.34
Accrued Liabilities1.811.871.451.421.26
Deferred Revenue0.930.000.000.000.00
Other Current Liabilities2.740.000.000.120.02
Total Current Liabilities15.5510.7311.855.878.54
Non-Current Liabilities
Long-Term Debt0.030.093.795.010.00
Other Non-Current Liabilities0.000.000.000.000.01
Total Non-Current Liabilities0.032.015.575.280.00
Total Liabilities15.5812.7417.4211.159.07
Stockholders' Equity
Common Stock0.010.010.000.020.01
Retained Earnings-493.48-480.50-467.19-446.91-433.51
Treasury Stock0.500.130.000.000.00
Additional Paid-in Capital485.02479.27473.63457.730.00
Shares Outstanding5.904.442.241.030.00
Total Stockholders' Equity-8.95-1.356.4510.843.03
Total Liabilities & Equity6.6311.3923.8721.980.00